244 related articles for article (PubMed ID: 25846830)
1. Serum microRNAs as Potential Biomarkers of Juvenile Idiopathic Arthritis.
Kamiya Y; Kawada J; Kawano Y; Torii Y; Kawabe S; Iwata N; Ito Y
Clin Rheumatol; 2015 Oct; 34(10):1705-12. PubMed ID: 25846830
[TBL] [Abstract][Full Text] [Related]
2. Differential plasma microRNAs expression in juvenile idiopathic arthritis.
Ma X; Wu F; Xin L; Su G; He F; Yang Y; Sun J; Liu Z
Mod Rheumatol; 2016; 26(2):224-32. PubMed ID: 26054419
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-18 as a mediator of systemic juvenile idiopathic arthritis.
Jelusić M; Lukić IK; Tambić-Bukovac L; Dubravcić K; Malcić I; Rudan I; Batinić D
Clin Rheumatol; 2007 Aug; 26(8):1332-4. PubMed ID: 17597334
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum receptor activator of NFkappaB ligand (RANKL), osteoprotegerin (OPG), matrix metalloproteinase (MMP)3, and ProMMP1 in patients with juvenile idiopathic arthritis.
Sarma PK; Misra R; Aggarwal A
Clin Rheumatol; 2008 Mar; 27(3):289-94. PubMed ID: 17703334
[TBL] [Abstract][Full Text] [Related]
5. Measurement of biomarkers in juvenile idiopathic arthritis patients and their significant association with disease severity: a comparative study.
Gilliam BE; Chauhan AK; Low JM; Moore TL
Clin Exp Rheumatol; 2008; 26(3):492-7. PubMed ID: 18578976
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory Markers and Disease Activity in Juvenile Idiopathic Arthritis.
Sarkar S; Alam MM; Das G; Datta S
Indian J Pediatr; 2017 May; 84(5):349-356. PubMed ID: 28176230
[TBL] [Abstract][Full Text] [Related]
7. Definitive differences in laboratory and radiological characteristics between two subtypes of juvenile idiopathic arthritis: systemic arthritis and polyarthritis.
Ozawa R; Inaba Y; Mori M; Hara R; Kikuchi M; Higuchi R; Miyamae T; Imagawa T; Fujiwara T; Saito T; Yokota S
Mod Rheumatol; 2012 Aug; 22(4):558-64. PubMed ID: 21984130
[TBL] [Abstract][Full Text] [Related]
8. The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus.
Bobek D; Grčević D; Kovačić N; Lukić IK; Jelušić M
Pediatr Rheumatol Online J; 2014; 12():50. PubMed ID: 25516724
[TBL] [Abstract][Full Text] [Related]
9. Regulation of JAK/STAT signal pathway by miR-21 in the pathogenesis of juvenile idiopathic arthritis.
Li HW; Zeng HS
World J Pediatr; 2020 Oct; 16(5):502-513. PubMed ID: 31641939
[TBL] [Abstract][Full Text] [Related]
10. Plasma miR-26a as a Diagnostic Biomarker Regulates Cytokine Expression in Systemic Juvenile Idiopathic Arthritis.
Sun J; Feng M; Wu F; Ma X; Lu J; Kang M; Liu Z
J Rheumatol; 2016 Aug; 43(8):1607-14. PubMed ID: 27252421
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of decreased serum concentration of cartilage oligomeric matrix protein in systemic juvenile idiopathic arthritis.
Urakami T; Manki A; Inoue T; Oda M; Tanaka H; Morishima T
J Rheumatol; 2006 May; 33(5):996-1000. PubMed ID: 16652429
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of plasma microRNA expressions in patients with juvenile idiopathic arthritis.
Demir F; Çebi AH; Kalyoncu M
Clin Rheumatol; 2018 Dec; 37(12):3255-3262. PubMed ID: 30171379
[TBL] [Abstract][Full Text] [Related]
13. Association of neopterin as a marker of immune system activation and juvenile rheumatoid arthritis activity.
Shady MM; Fathy HA; Ali A; Youness ER; Fathy GA
J Pediatr (Rio J); 2015; 91(4):352-7. PubMed ID: 25727025
[TBL] [Abstract][Full Text] [Related]
14. Circulating levels of the adipokines vaspin and omentin in patients with juvenile idiopathic arthritis, and relation to disease activity.
Cantarini L; Simonini G; Fioravanti A; Generoso M; Bacarelli MR; Dini E; Galeazzi M; Cimaz R
Clin Exp Rheumatol; 2011; 29(6):1044-8. PubMed ID: 22032341
[TBL] [Abstract][Full Text] [Related]
15. Influence of Matrix metalloproteinase 1 and 3 genetic variations on susceptibility and severity of juvenile idiopathic arthritis.
Abd-Allah SH; El-Shal AS; Shalaby SM; Pasha HF; Abou El-Saoud AM; Abdel Galil SM; Mahmoud TA
IUBMB Life; 2015 Dec; 67(12):934-42. PubMed ID: 26510114
[TBL] [Abstract][Full Text] [Related]
16. 90K immunostimulatory glycoprotein in children with juvenile idiopathic arthritis.
Cecamore C; Marsili M; Salvatore R; Troiani R; D'Egidio M; Tinari N; Pelliccia P; Chiarelli F; Marcovecchio ML; Breda L
Mod Rheumatol; 2018 Jul; 28(4):637-641. PubMed ID: 29157059
[TBL] [Abstract][Full Text] [Related]
17. Synovial-Fluid miRNA Signature for Diagnosis of Juvenile Idiopathic Arthritis.
Nziza N; Jeziorski E; Delpont M; Cren M; Chevassus H; Carbasse A; Mahe P; Abassi H; Joly-Monrigal P; Schordan E; Mangé A; Jorgensen C; Apparailly F; Duroux-Richard I
Cells; 2019 Nov; 8(12):. PubMed ID: 31779271
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of selected biomarkers, polymorphisms, and clinical features for oligoarticular juvenile idiopathic arthritis-associated uveitis.
Pelegrín L; Casaroli-Marano R; Antón J; García de Vicuña MC; Molina-Prat N; Ignacio Aróstegui J; Yagüe J; Ríos J; Adán A
Ocul Immunol Inflamm; 2014 Jun; 22(3):208-12. PubMed ID: 24131380
[TBL] [Abstract][Full Text] [Related]
19. Soluble adhesion molecules ICAM-1 and E-selectin in juvenile arthritis: clinical and laboratory correlations.
Dolezalová P; Telekesová P; Nemcová D; Hoza J
Clin Exp Rheumatol; 2002; 20(2):249-54. PubMed ID: 12051408
[TBL] [Abstract][Full Text] [Related]
20. Soluble ST2 as a marker of disease activity in systemic juvenile idiopathic arthritis.
Ishikawa S; Shimizu M; Ueno K; Sugimoto N; Yachie A
Cytokine; 2013 May; 62(2):272-7. PubMed ID: 23561929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
